125 related articles for article (PubMed ID: 35489663)
1. Dynamic network biomarker analysis and system pharmacology methods to explore the therapeutic effects and targets of Xiaoyaosan against liver cirrhosis.
Lu Y; Li M; Zhou Q; Fang D; Wu R; Li Q; Chen L; Su S
J Ethnopharmacol; 2022 Aug; 294():115324. PubMed ID: 35489663
[TBL] [Abstract][Full Text] [Related]
2. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
[TBL] [Abstract][Full Text] [Related]
3. Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus.
Jiao H; Fan Y; Gong A; Li T; Fu X; Yan Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116938. PubMed ID: 37495029
[TBL] [Abstract][Full Text] [Related]
4. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
[TBL] [Abstract][Full Text] [Related]
5. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
[TBL] [Abstract][Full Text] [Related]
6. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant Mechanism of Traditional Chinese Medicine Formula Xiaoyaosan in CUMS-Induced Depressed Mouse Model via RIPK1-RIPK3-MLKL Mediated Necroptosis Based on Network Pharmacology Analysis.
Yan ZY; Jiao HY; Chen JB; Zhang KW; Wang XH; Jiang YM; Liu YY; Xue Z; Ma QY; Li XJ; Chen JX
Front Pharmacol; 2021; 12():773562. PubMed ID: 34867405
[No Abstract] [Full Text] [Related]
8. Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Sun MY; Su SB
Pharm Biol; 2021 Dec; 59(1):1594-1606. PubMed ID: 34808067
[TBL] [Abstract][Full Text] [Related]
9. Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation.
Chen M; Luo Y; Men L; Lin B; Lin H; Li Y; Zhong G; Zhong X; Fu W; Zhou H; Tong G; Liu Q; Luan J
Aging (Albany NY); 2021 Apr; 13(8):11411-11432. PubMed ID: 33839698
[TBL] [Abstract][Full Text] [Related]
10. Integrating hippocampal metabolomics and network pharmacology deciphers the antidepressant mechanisms of Xiaoyaosan.
Liu X; Wei F; Liu H; Zhao S; Du G; Qin X
J Ethnopharmacol; 2021 Mar; 268():113549. PubMed ID: 33152435
[TBL] [Abstract][Full Text] [Related]
11. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
12. [An exploration in the action targets for antidepressant bioactive components of Xiaoyaosan based on network pharmacology].
Gao Y; Gao L; Gao XX; Zhou YZ; Qin XM; Tian JS
Yao Xue Xue Bao; 2015 Dec; 50(12):1589-95. PubMed ID: 27169281
[TBL] [Abstract][Full Text] [Related]
13. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
Li M; Shang H; Wang T; Yang SQ; Li L
World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Hepatic SHIP2 and PI3K/Akt Signalling in the Regulation of Plasma Insulin by Xiaoyaosan in Chronic Immobilization-Stressed Rats.
Pan Q; Wu J; Liu Y; Li X; Chen J
Molecules; 2019 Jan; 24(3):. PubMed ID: 30699999
[TBL] [Abstract][Full Text] [Related]
15. Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.
Huang J; Guo W; Cheung F; Tan HY; Wang N; Feng Y
Am J Chin Med; 2020; 48(1):161-182. PubMed ID: 31964157
[TBL] [Abstract][Full Text] [Related]
16. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
[TBL] [Abstract][Full Text] [Related]
17. The synergistic anti-depression effects of different efficacy groups of Xiaoyaosan as demonstrated by the integration of network pharmacology and serum metabolomics.
Liu XJ; Wang YZ; Wei FX; Lv M; Qu P; Chen SJ; Li SY; Qin X
J Pharm Biomed Anal; 2021 Apr; 197():113949. PubMed ID: 33618131
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics study on the anti-depression effect of xiaoyaosan on rat model of chronic unpredictable mild stress.
Dai Y; Li Z; Xue L; Dou C; Zhou Y; Zhang L; Qin X
J Ethnopharmacol; 2010 Mar; 128(2):482-9. PubMed ID: 20079416
[TBL] [Abstract][Full Text] [Related]
19. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
20. Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach.
Liu CC; Wu YF; Feng GM; Gao XX; Zhou YZ; Hou WJ; Qin XM; Du GH; Tian JS
J Affect Disord; 2015 Oct; 185():156-63. PubMed ID: 26186531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
